- Home
- TGL vs RLAY Comparison
TGL vs RLAY Comparison
Compare TGL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- RLAY
- Stock Information
- Founded
- TGL 2020
- RLAY 2015
- Country
- TGL United States
- RLAY United States
- Employees
- TGL N/A
- RLAY N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TGL Technology
- RLAY Health Care
- Exchange
- TGL Nasdaq
- RLAY Nasdaq
- Market Cap
- TGL 4.1M
- RLAY 576.1M
- IPO Year
- TGL 2022
- RLAY 2020
- Fundamental
- Price
- TGL $1.22
- RLAY $3.63
- Analyst Decision
- TGL
- RLAY Strong Buy
- Analyst Count
- TGL 0
- RLAY 11
- Target Price
- TGL N/A
- RLAY $18.40
- AVG Volume (30 Days)
- TGL 1.7M
- RLAY 1.6M
- Earning Date
- TGL 08-25-2025
- RLAY 08-05-2025
- Dividend Yield
- TGL N/A
- RLAY N/A
- EPS Growth
- TGL N/A
- RLAY N/A
- EPS
- TGL N/A
- RLAY N/A
- Revenue
- TGL $1,468,790.00
- RLAY $7,679,000.00
- Revenue This Year
- TGL N/A
- RLAY $14.31
- Revenue Next Year
- TGL N/A
- RLAY N/A
- P/E Ratio
- TGL N/A
- RLAY N/A
- Revenue Growth
- TGL N/A
- RLAY N/A
- 52 Week Low
- TGL $1.01
- RLAY $1.78
- 52 Week High
- TGL $145.00
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- TGL 47.15
- RLAY 63.22
- Support Level
- TGL $1.22
- RLAY $3.10
- Resistance Level
- TGL $1.11
- RLAY $3.75
- Average True Range (ATR)
- TGL 0.08
- RLAY 0.23
- MACD
- TGL 0.05
- RLAY 0.03
- Stochastic Oscillator
- TGL 82.35
- RLAY 84.42
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).